FR2373513A1 - Nouveaux derives du naphtalene, leur preparation et leur application comme medicaments - Google Patents

Nouveaux derives du naphtalene, leur preparation et leur application comme medicaments

Info

Publication number
FR2373513A1
FR2373513A1 FR7736662A FR7736662A FR2373513A1 FR 2373513 A1 FR2373513 A1 FR 2373513A1 FR 7736662 A FR7736662 A FR 7736662A FR 7736662 A FR7736662 A FR 7736662A FR 2373513 A1 FR2373513 A1 FR 2373513A1
Authority
FR
France
Prior art keywords
preparation
application
naphthalene derivatives
medicinal products
new naphthalene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7736662A
Other languages
English (en)
French (fr)
Other versions
FR2373513B1 (ja
Inventor
Janos Pless
Max-Peter Seiler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2373513A1 publication Critical patent/FR2373513A1/fr
Application granted granted Critical
Publication of FR2373513B1 publication Critical patent/FR2373513B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7736662A 1976-12-07 1977-12-06 Nouveaux derives du naphtalene, leur preparation et leur application comme medicaments Granted FR2373513A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1535376 1976-12-07
CH8277 1977-01-05

Publications (2)

Publication Number Publication Date
FR2373513A1 true FR2373513A1 (fr) 1978-07-07
FR2373513B1 FR2373513B1 (ja) 1980-08-22

Family

ID=25683446

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7736662A Granted FR2373513A1 (fr) 1976-12-07 1977-12-06 Nouveaux derives du naphtalene, leur preparation et leur application comme medicaments

Country Status (17)

Country Link
JP (1) JPS5384955A (ja)
AT (1) AT366361B (ja)
CA (1) CA1105475A (ja)
DE (1) DE2752659A1 (ja)
DK (1) DK527877A (ja)
ES (1) ES464747A1 (ja)
FI (1) FI773595A (ja)
FR (1) FR2373513A1 (ja)
GB (1) GB1597140A (ja)
IE (1) IE45929B1 (ja)
IL (1) IL53533A (ja)
NL (1) NL7713364A (ja)
NZ (1) NZ185884A (ja)
PH (1) PH13932A (ja)
PT (1) PT67365B (ja)
SE (1) SE7713471L (ja)
SU (1) SU927110A3 (ja)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033789A1 (en) * 1980-01-30 1981-08-19 American Hospital Supply Corporation 2-alpha-Methyl-dopaminimino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, its salts, and a process for preparation thereof
WO1981003491A1 (en) * 1980-05-29 1981-12-10 Astra Laekemedel Ab Therapeutically useful tetralin derivatives
US4314082A (en) * 1978-07-14 1982-02-02 American Hospital Supply Corporation Derivatives of 2-amino-6,7-dihydroxytetrahydro naphthalene (ADTN)
EP0016148B1 (en) * 1978-07-14 1983-07-13 American Hospital Supply Corporation 2-alpha-methyl-dopaminimino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, its salts, and a process for preparation thereof
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0026848B1 (de) 1979-09-14 1983-05-04 Sandoz Ag Tetralinderivate, ihre Herstellung und Heilmittel, welche diese Verbindungen enthalten
IL65501A (en) * 1981-05-08 1986-04-29 Astra Laekemedel Ab 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
WO1982004042A1 (en) * 1981-05-11 1982-11-25 Folke Lars Erik Arvidsson Therapeutically useful tetralin derivatives iii,processes for preparation and pharmaceutical preparations for such compounds
US4402974A (en) 1981-06-23 1983-09-06 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche
US4500545A (en) * 1982-11-16 1985-02-19 Eli Lilly And Company Hydroxyaminotetralincarboxamides
US4448990A (en) * 1982-11-16 1984-05-15 Eli Lilly And Company Hydroxyaminotetralincarboxamides
US4743618A (en) * 1983-01-03 1988-05-10 Nelson Research & Development Co. Substituted 2-aminotetralins
US4722933A (en) * 1985-12-20 1988-02-02 Nelson Research & Development Co. Substituted 2-aminotetralins
US4657925A (en) * 1984-08-13 1987-04-14 Nelson Research & Development Co. Method and compositions for reducing the intraocular pressure of mammals
US5177112A (en) * 1983-01-03 1993-01-05 Whitby Research, Inc. Substituted 2-aminotetralins
US4564628A (en) * 1983-01-03 1986-01-14 Nelson Research & Development Co. Substituted 2-aminotetralins
GB2157950B (en) * 1984-05-04 1988-11-02 Nelson Res & Dev Selective d-2 dopamine receptor agonist
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
CA1331191C (en) 1988-03-25 1994-08-02 Bengt Ronny Andersson Therapeutically useful tetralin derivatives
US5225596A (en) * 1989-01-09 1993-07-06 The Upjohn Company Halo substituted aminotetralins
JP2931986B2 (ja) * 1989-02-17 1999-08-09 武田薬品工業株式会社 アラルキルアミン誘導体
SE8901889D0 (sv) * 1989-05-26 1989-05-26 Astra Ab Novel 8-substituted-2-aminotetralines
WO1992015553A1 (fr) * 1991-03-07 1992-09-17 Zeria Pharmaceutical Co., Ltd. Derive de trialkylamine et adjuvant de motilite de l'appareil digestif le contenant
EP0923542B1 (en) * 1996-05-31 2003-08-20 PHARMACIA & UPJOHN COMPANY Aryl substituted cyclic amines as selective dopamine d3 ligands
IT1294931B1 (it) 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
AR054363A1 (es) * 2005-05-23 2007-06-20 Astrazeneca Ab Compuestos que exhiben actividad moduladora en el receptor 5-hidroxi-triptamina 6
US8809590B2 (en) * 2011-06-27 2014-08-19 Shan Dong Luye Pharmaceutical Co., Ltd. Method for industrially preparing nitrogen substituted amino-5,6,7,8-tetrahydronaphthol

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2190464A1 (ja) * 1972-07-03 1974-02-01 Squibb & Sons Inc

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2190464A1 (ja) * 1972-07-03 1974-02-01 Squibb & Sons Inc

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CA1973 *
NV2030/74 *
NV2054/72 *
NV2054/76 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314082A (en) * 1978-07-14 1982-02-02 American Hospital Supply Corporation Derivatives of 2-amino-6,7-dihydroxytetrahydro naphthalene (ADTN)
EP0016148B1 (en) * 1978-07-14 1983-07-13 American Hospital Supply Corporation 2-alpha-methyl-dopaminimino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, its salts, and a process for preparation thereof
EP0033789A1 (en) * 1980-01-30 1981-08-19 American Hospital Supply Corporation 2-alpha-Methyl-dopaminimino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, its salts, and a process for preparation thereof
WO1981003491A1 (en) * 1980-05-29 1981-12-10 Astra Laekemedel Ab Therapeutically useful tetralin derivatives
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents

Also Published As

Publication number Publication date
NL7713364A (nl) 1978-06-09
AT366361B (de) 1982-04-13
SE7713471L (sv) 1978-06-08
PT67365A (fr) 1978-01-01
JPS6214540B2 (ja) 1987-04-02
IE45929B1 (en) 1982-12-29
FR2373513B1 (ja) 1980-08-22
CA1105475A (en) 1981-07-21
PH13932A (en) 1980-11-04
DK527877A (da) 1978-06-08
IL53533A (en) 1982-07-30
DE2752659A1 (de) 1978-06-08
PT67365B (fr) 1979-09-20
NZ185884A (en) 1980-04-28
FI773595A (fi) 1978-06-08
IL53533A0 (en) 1978-03-10
SU927110A3 (ru) 1982-05-07
ES464747A1 (es) 1979-01-01
ATA871977A (de) 1981-08-15
JPS5384955A (en) 1978-07-26
GB1597140A (en) 1981-09-03
IE45929L (en) 1978-06-07

Similar Documents

Publication Publication Date Title
FR2373513A1 (fr) Nouveaux derives du naphtalene, leur preparation et leur application comme medicaments
FR2398748A1 (fr) Nouveaux derives d'imidazoquinazoline, leur preparation et leur application en tant que medicaments
FR2390420A1 (fr) Nouveaux derives cyclopeptidiques, leur preparation et leur application comme medicaments
FR2367053A1 (fr) Nouveaux derives de phenoxy-amino-propanol, leur preparation et leur application en tant que medicaments
FR2430419A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2360587A1 (fr) Nouveaux derives d'amino-alcoyl-furannes utiles comme medicaments
FR2390428A1 (fr) Nouveaux composes polyeniques, leur preparation et leur application en tant que medicaments
FR2422643A1 (fr) Nouveaux derives d'imidazolidine, leur preparation et leur application comme medicaments
FR2436149A1 (fr) Nouveaux aminoglucosides, leur preparation et leur application comme medicaments
FR2398058A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2445330A1 (fr) Derives du 11-bromo-14,15-dioxo-e-homo-eburnane leur preparation et leur utilisation comme medicament
FR2415636A1 (fr) Nouveaux derives de la guanidine, leur preparation et leur application comme medicaments
FR2379533A1 (fr) Tetrazolylcarbamoylquinoleines utilisables comme medicaments et leur preparation
FR2370745A1 (fr) Nouveaux derives de la morphanthridine, leur preparation et leur application comme medicaments
FR2401160A1 (fr) Nouveaux derives d'esters de vincaminol, leur preparation et leur application en tant que medicaments
FR2379538A1 (fr) Nouveaux derives d'oxadiazolopyrimidine, leur preparation et leur application en tant que medicaments
FR2375211A1 (fr) Nouveaux acides sulfamoylbenzoiques, leur preparation et leur application en tant que medicaments
FR2378015A1 (fr) Nouveaux derives de la benzo(f)isoquinoleine, leur preparation et leur application comme medicaments
FR2379532A1 (fr) Nouveaux derives de l'acide oxamique, leur preparation et leur application comme medicaments
FR2378781A1 (fr) Nouveaux derives d'alcaloides de l'ergot de seigle, leur preparation et leur application comme medicaments
FR2432506A1 (fr) Nouveaux derives de 6-methoxy-2-acetylnaphtalene oxime, leur preparation et leur application en tant que medicaments
FR2392011A1 (fr) Nouveaux derives de la 5-phenyl-1h-3-benzazepine, leur preparation et leur utilisation comme medicaments
FR2366289A1 (fr) Nouveaux derives de l'imidazo(5,1-a)isoquinoleine, leur preparation et leur application comme medicaments
FR2416885A1 (fr) Nouveaux derives d'acides gras a longue chaine, leur preparation et leur application comme medicaments
FR2365557A1 (fr) Nouveaux perhydro-indolinols, leur preparation et leur application comme medicaments

Legal Events

Date Code Title Description
ST Notification of lapse